サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1577424

IgEアレルギー血液検査市場：製品タイプ、検査タイプ、用途、エンドユーザー、アレルゲンタイプ、流通チャネル別-2025-2030年世界予測

IgE Allergy Blood Tests Market by Product Type (Instruments, Kits, Reagents), Test Type (Specific IgE Test, Total IgE Test), Application, End User, Allergen Type, Distribution Channel - Global Forecast 2025-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 195 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.86円
IgEアレルギー血液検査市場：製品タイプ、検査タイプ、用途、エンドユーザー、アレルゲンタイプ、流通チャネル別-2025-2030年世界予測
出版日: 2024年10月25日
発行: 360iResearch
ページ情報: 英文 195 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

IgEアレルギー血液検査市場は、2023年に298億7,000万米ドルと評価され、2024年には314億9,000万米ドルに達すると予測され、CAGR 5.29％で成長し、2030年には428億7,000万米ドルになると予測されています。

IgEアレルギー血液検査市場の範囲には、アレルギー状態を診断するための血液中のアレルゲン特異的免疫グロブリンE（IgE）レベルの定量化が含まれます。これらの検査は、ヘルスケアプロバイダーが過敏反応の原因となるアレルゲンを特定するために不可欠であり、特に皮膚疾患のある患者や他の検査法を妨害する薬剤を服用している患者において、皮膚検査と比較してアレルギーを診断するための包括的なソリューションを提供します。このアプリケーションは主に、病院、診断研究所、研究機関など、さまざまなヘルスケア環境におけるアレルギー性鼻炎、喘息、食物アレルギー、アトピー性皮膚炎の診断に関連します。最終用途には、原因不明の呼吸器症状や皮膚症状により正確なアレルギー診断を必要とする患者や、食物アレルギーが疑われる患者が含まれます。

主な市場の統計
基準年［2023］ 298億7,000万米ドル
予測年［2024] 314億9,000万米ドル
予測年［2030］ 428億7,000万米ドル
CAGR（%） 5.29%

この市場の主な成長要因としては、アレルギー疾患の有病率の増加、早期診断に関する意識の高まり、感度と特異度を向上させる免疫学的測定法の技術進歩などが挙げられます。ヘルスケア・インフラが急速に発展し、個別化医療への投資が増加している新興国市場には機会が豊富にあります。これらを活用するために、企業は地理的拡大やヘルスケアプロバイダーとの戦略的提携に注力し、アクセシビリティを高める必要があります。自動検査プラットフォームの革新とマルチプレックスアッセイの開拓により、市場浸透を大幅に促進できます。

課題としては、検査コストの高さ、規制遵守の複雑さ、安価で臨床実施が容易な皮膚プリックテストなどの代替診断法との競合などが挙げられます。さらに、特定の地域における認知度の低さが市場成長の妨げとなっています。こうした制約に対処するため、企業は費用対効果の高い製造技術や広範な市場啓蒙キャンペーンに投資することができます。

技術革新の分野には、ハイスループット・スクリーニング検査の開発、予測診断のための人工知能の統合、精度と信頼性を向上させるためのアレルゲン・データベースの拡大などがあります。競合考察によると、市場競争は激しいが、拡張性のあるイノベーションを採用し、患者中心のソリューションに注力する企業にとってはやりがいのある市場です。手頃な価格、正確性、利用しやすさを戦略的に重視することで、市場の成長を促進し、診断能力を拡大することができます。

市場力学：急速に進化するIgEアレルギー血液検査市場の主要市場インサイトを公開

IgEアレルギー血液検査市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

  • 市場促進要因
    • IgEアレルギー血液検査を含む診断検査需要の増加につながるアレルギーの有病率の増加
    • より正確で信頼性の高いIgEアレルギー血液検査に貢献する診断機器の技術進歩
    • アレルギーの早期発見と早期管理の利点に対する患者やヘルスケア提供者の意識の高まり
    • IgEアレルギー血液検査へのアクセスを容易にする医療費の増加と医療インフラの改善
  • 市場抑制要因
    • IgEアレルギー血液検査のコストが高いため、患者やヘルスケア提供者の間で導入が制限されていること
    • 訓練を受けた専門家や専門的な検査室が限られていることが、遠隔地や十分なサービスを受けていない地域でのIgEアレルギー血液検査の普及を妨げています。
  • 市場機会
    • アレルギー検査・管理を推進する政府のイニシアチブにより、IgE検査の普及が進む
    • 新興市場におけるヘルスケアインフラの拡大がIgEアレルギー血液検査の成長を促進
    • 診断ラボとヘルスケアプロバイダーのパートナーシップによるIgE検査市場の拡大
  • 市場の課題
    • 医療従事者や患者におけるIgE血液検査に対する認識と理解が不十分
    • 新しい検査法の承認プロセスを複雑にしている断片的な規制状況

ポーターの5つの力：IgEアレルギー血液検査市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：IgEアレルギー血液検査市場における外部からの影響の把握

外部マクロ環境要因は、IgEアレルギー血液検査市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析IgEアレルギー血液検査市場における競合情勢の把握

IgEアレルギー血液検査市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスIgEアレルギー血液検査市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、IgEアレルギー血液検査市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨IgEアレルギー血液検査市場における成功への道筋を描く

IgEアレルギー血液検査市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • アレルギーの罹患率の増加により、IgEアレルギー血液検査を含む診断検査の需要が高まっています。
      • 診断機器の技術的進歩により、より正確で信頼性の高いIgEアレルギー血液検査
      • アレルギーの早期発見と管理の利点について、患者とヘルスケア従事者の間で認識が高まっている
      • ヘルスケア費の増加とヘルスケアインフラの改善により、IgEアレルギー血液検査へのアクセスが容易になった。
    • 抑制要因
      • IgEアレルギー血液検査のコストが高いため、患者とヘルスケア提供者の間での採用が制限されている
      • 訓練を受けた専門家や専門の研究所が限られているため、遠隔地やサービスが行き届いていない地域ではIgEアレルギー血液検査の普及が妨げられています。
    • 機会
      • アレルギー検査と管理を推進する政府の取り組みにより、IgE検査の採用が増加
      • 新興市場におけるヘルスケアインフラの拡大がIgEアレルギー血液検査の成長を牽引
      • 診断ラボとヘルスケア提供者の提携によりIgE検査市場が拡大
    • 課題
      • ヘルスケア従事者と患者の間でIgE血液検査に対する認識と理解が限られている
      • 断片化された規制状況が新しい試験方法の承認プロセスを複雑化
  • 市場セグメンテーション分析
  • ポーターのファイブフォース分析
  • PESTEL分析
    • 政治的
    • 経済
    • 社交
    • 技術的
    • 法律上
    • 環境

第6章 IgEアレルギー血液検査市場：製品タイプ別

  • 機器
  • キット
    • カスタムキット
    • 標準キット
  • 試薬

第7章 IgEアレルギー血液検査市場テストタイプ別

  • 特異的IgE検査
  • 総IgE検査

第8章 IgEアレルギー血液検査市場：用途別

  • 診断
  • 医薬品開発
  • 調査

第9章 IgEアレルギー血液検査市場：エンドユーザー別

  • 学術研究機関
  • 病院
    • 私立病院
    • 公立病院
  • 製薬・バイオテクノロジー企業
  • リファレンスラボ

第10章 IgEアレルギー血液検査市場アレルゲンの種類別

  • 動物アレルゲン
  • 薬物アレルゲン
  • 食物アレルゲン
    • 卵
    • ミルク
    • 落花生
    • シーフード
    • 大豆
    • 木の実
    • 小麦
  • 吸入アレルゲン
    • ダニ
    • 型
    • 花粉

第11章 IgEアレルギー血液検査市場：流通チャネル別

  • 直接販売
  • 代理店販売

第12章 南北アメリカのIgEアレルギー血液検査市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第13章 アジア太平洋地域のIgEアレルギー血液検査市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第14章 欧州・中東・アフリカのIgEアレルギー血液検査市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第15章 競合情勢

  • 市場シェア分析2023
  • FPNVポジショニングマトリックス, 2023
  • 競合シナリオ分析
  • 戦略分析と提言

企業一覧

  • 1. Abcam plc
  • 2. Allergy Therapeutics
  • 3. Bindley Western Industries, Inc.
  • 4. bioMerieux SA
  • 5. Creative Diagnostics
  • 6. Danaher Corporation
  • 7. DRG International, Inc.
  • 8. EUROIMMUN Medizinische Labordiagnostika AG
  • 9. HYCOR Biomedical, Inc.
  • 10. Lincoln Diagnostics, Inc.
  • 11. MEDIWISS ANALYTIC GmbH
  • 12. Meso Scale Diagnostics, LLC
  • 13. Omega Diagnostics Group PLC
  • 14. PerkinElmer, Inc.
  • 15. R-Biopharm AG
  • 16. Randox Laboratories Ltd.
  • 17. Siemens Healthineers AG
  • 18. Stallergenes Greer Ltd
  • 19. Tecan Group Ltd.
  • 20. Thermo Fisher Scientific Inc.
図表

LIST OF FIGURES

  • FIGURE 1. IGE ALLERGY BLOOD TESTS MARKET RESEARCH PROCESS
  • FIGURE 2. IGE ALLERGY BLOOD TESTS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL IGE ALLERGY BLOOD TESTS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY ALLERGEN TYPE, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY ALLERGEN TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 17. GLOBAL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS IGE ALLERGY BLOOD TESTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. AMERICAS IGE ALLERGY BLOOD TESTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES IGE ALLERGY BLOOD TESTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 21. UNITED STATES IGE ALLERGY BLOOD TESTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC IGE ALLERGY BLOOD TESTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC IGE ALLERGY BLOOD TESTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 26. IGE ALLERGY BLOOD TESTS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 27. IGE ALLERGY BLOOD TESTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. IGE ALLERGY BLOOD TESTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL IGE ALLERGY BLOOD TESTS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. IGE ALLERGY BLOOD TESTS MARKET DYNAMICS
  • TABLE 7. GLOBAL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY CUSTOM KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY STANDARD KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY SPECIFIC IGE TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY TOTAL IGE TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY ANIMAL ALLERGENS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY DRUG ALLERGENS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY FOOD ALLERGENS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY EGG, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY MILK, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY PEANUT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY SEAFOOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY SOY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY TREE NUTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY WHEAT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY INHALANT ALLERGENS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY DUST MITES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY MOLD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY POLLEN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY INHALANT ALLERGENS, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS IGE ALLERGY BLOOD TESTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS IGE ALLERGY BLOOD TESTS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS IGE ALLERGY BLOOD TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS IGE ALLERGY BLOOD TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS IGE ALLERGY BLOOD TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. AMERICAS IGE ALLERGY BLOOD TESTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 55. AMERICAS IGE ALLERGY BLOOD TESTS MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. AMERICAS IGE ALLERGY BLOOD TESTS MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
  • TABLE 57. AMERICAS IGE ALLERGY BLOOD TESTS MARKET SIZE, BY INHALANT ALLERGENS, 2018-2030 (USD MILLION)
  • TABLE 58. AMERICAS IGE ALLERGY BLOOD TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 59. AMERICAS IGE ALLERGY BLOOD TESTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 60. ARGENTINA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. ARGENTINA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 62. ARGENTINA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. ARGENTINA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. ARGENTINA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. ARGENTINA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 66. ARGENTINA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. ARGENTINA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
  • TABLE 68. ARGENTINA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY INHALANT ALLERGENS, 2018-2030 (USD MILLION)
  • TABLE 69. ARGENTINA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 70. BRAZIL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. BRAZIL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 72. BRAZIL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. BRAZIL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. BRAZIL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. BRAZIL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 76. BRAZIL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. BRAZIL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
  • TABLE 78. BRAZIL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY INHALANT ALLERGENS, 2018-2030 (USD MILLION)
  • TABLE 79. BRAZIL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 80. CANADA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. CANADA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 82. CANADA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. CANADA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. CANADA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. CANADA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 86. CANADA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. CANADA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
  • TABLE 88. CANADA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY INHALANT ALLERGENS, 2018-2030 (USD MILLION)
  • TABLE 89. CANADA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 90. MEXICO IGE ALLERGY BLOOD TESTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. MEXICO IGE ALLERGY BLOOD TESTS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 92. MEXICO IGE ALLERGY BLOOD TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. MEXICO IGE ALLERGY BLOOD TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. MEXICO IGE ALLERGY BLOOD TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. MEXICO IGE ALLERGY BLOOD TESTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 96. MEXICO IGE ALLERGY BLOOD TESTS MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. MEXICO IGE ALLERGY BLOOD TESTS MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
  • TABLE 98. MEXICO IGE ALLERGY BLOOD TESTS MARKET SIZE, BY INHALANT ALLERGENS, 2018-2030 (USD MILLION)
  • TABLE 99. MEXICO IGE ALLERGY BLOOD TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED STATES IGE ALLERGY BLOOD TESTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED STATES IGE ALLERGY BLOOD TESTS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED STATES IGE ALLERGY BLOOD TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED STATES IGE ALLERGY BLOOD TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. UNITED STATES IGE ALLERGY BLOOD TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 105. UNITED STATES IGE ALLERGY BLOOD TESTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 106. UNITED STATES IGE ALLERGY BLOOD TESTS MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. UNITED STATES IGE ALLERGY BLOOD TESTS MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
  • TABLE 108. UNITED STATES IGE ALLERGY BLOOD TESTS MARKET SIZE, BY INHALANT ALLERGENS, 2018-2030 (USD MILLION)
  • TABLE 109. UNITED STATES IGE ALLERGY BLOOD TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 110. UNITED STATES IGE ALLERGY BLOOD TESTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC IGE ALLERGY BLOOD TESTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC IGE ALLERGY BLOOD TESTS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC IGE ALLERGY BLOOD TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC IGE ALLERGY BLOOD TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC IGE ALLERGY BLOOD TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC IGE ALLERGY BLOOD TESTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC IGE ALLERGY BLOOD TESTS MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC IGE ALLERGY BLOOD TESTS MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC IGE ALLERGY BLOOD TESTS MARKET SIZE, BY INHALANT ALLERGENS, 2018-2030 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC IGE ALLERGY BLOOD TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC IGE ALLERGY BLOOD TESTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 122. AUSTRALIA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. AUSTRALIA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 124. AUSTRALIA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. AUSTRALIA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. AUSTRALIA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. AUSTRALIA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 128. AUSTRALIA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. AUSTRALIA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
  • TABLE 130. AUSTRALIA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY INHALANT ALLERGENS, 2018-2030 (USD MILLION)
  • TABLE 131. AUSTRALIA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 132. CHINA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. CHINA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 134. CHINA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. CHINA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. CHINA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. CHINA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 138. CHINA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. CHINA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
  • TABLE 140. CHINA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY INHALANT ALLERGENS, 2018-2030 (USD MILLION)
  • TABLE 141. CHINA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 142. INDIA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. INDIA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 144. INDIA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. INDIA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. INDIA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 147. INDIA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 148. INDIA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. INDIA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
  • TABLE 150. INDIA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY INHALANT ALLERGENS, 2018-2030 (USD MILLION)
  • TABLE 151. INDIA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 152. INDONESIA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. INDONESIA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 154. INDONESIA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. INDONESIA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. INDONESIA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 157. INDONESIA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 158. INDONESIA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. INDONESIA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
  • TABLE 160. INDONESIA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY INHALANT ALLERGENS, 2018-2030 (USD MILLION)
  • TABLE 161. INDONESIA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 162. JAPAN IGE ALLERGY BLOOD TESTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. JAPAN IGE ALLERGY BLOOD TESTS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 164. JAPAN IGE ALLERGY BLOOD TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. JAPAN IGE ALLERGY BLOOD TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. JAPAN IGE ALLERGY BLOOD TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 167. JAPAN IGE ALLERGY BLOOD TESTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 168. JAPAN IGE ALLERGY BLOOD TESTS MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. JAPAN IGE ALLERGY BLOOD TESTS MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
  • TABLE 170. JAPAN IGE ALLERGY BLOOD TESTS MARKET SIZE, BY INHALANT ALLERGENS, 2018-2030 (USD MILLION)
  • TABLE 171. JAPAN IGE ALLERGY BLOOD TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 172. MALAYSIA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. MALAYSIA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 174. MALAYSIA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. MALAYSIA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. MALAYSIA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 177. MALAYSIA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 178. MALAYSIA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. MALAYSIA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
  • TABLE 180. MALAYSIA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY INHALANT ALLERGENS, 2018-2030 (USD MILLION)
  • TABLE 181. MALAYSIA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 182. PHILIPPINES IGE ALLERGY BLOOD TESTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. PHILIPPINES IGE ALLERGY BLOOD TESTS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 184. PHILIPPINES IGE ALLERGY BLOOD TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. PHILIPPINES IGE ALLERGY BLOOD TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. PHILIPPINES IGE ALLERGY BLOOD TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 187. PHILIPPINES IGE ALLERGY BLOOD TESTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 188. PHILIPPINES IGE ALLERGY BLOOD TESTS MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. PHILIPPINES IGE ALLERGY BLOOD TESTS MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
  • TABLE 190. PHILIPPINES IGE ALLERGY BLOOD TESTS MARKET SIZE, BY INHALANT ALLERGENS, 2018-2030 (USD MILLION)
  • TABLE 191. PHILIPPINES IGE ALLERGY BLOOD TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 192. SINGAPORE IGE ALLERGY BLOOD TESTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. SINGAPORE IGE ALLERGY BLOOD TESTS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 194. SINGAPORE IGE ALLERGY BLOOD TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. SINGAPORE IGE ALLERGY BLOOD TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. SINGAPORE IGE ALLERGY BLOOD TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 197. SINGAPORE IGE ALLERGY BLOOD TESTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 198. SINGAPORE IGE ALLERGY BLOOD TESTS MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. SINGAPORE IGE ALLERGY BLOOD TESTS MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
  • TABLE 200. SINGAPORE IGE ALLERGY BLOOD TESTS MARKET SIZE, BY INHALANT ALLERGENS, 2018-2030 (USD MILLION)
  • TABLE 201. SINGAPORE IGE ALLERGY BLOOD TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH KOREA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH KOREA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH KOREA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH KOREA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH KOREA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH KOREA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 208. SOUTH KOREA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. SOUTH KOREA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
  • TABLE 210. SOUTH KOREA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY INHALANT ALLERGENS, 2018-2030 (USD MILLION)
  • TABLE 211. SOUTH KOREA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 212. TAIWAN IGE ALLERGY BLOOD TESTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. TAIWAN IGE ALLERGY BLOOD TESTS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 214. TAIWAN IGE ALLERGY BLOOD TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. TAIWAN IGE ALLERGY BLOOD TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 216. TAIWAN IGE ALLERGY BLOOD TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 217. TAIWAN IGE ALLERGY BLOOD TESTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 218. TAIWAN IGE ALLERGY BLOOD TESTS MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. TAIWAN IGE ALLERGY BLOOD TESTS MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
  • TABLE 220. TAIWAN IGE ALLERGY BLOOD TESTS MARKET SIZE, BY INHALANT ALLERGENS, 2018-2030 (USD MILLION)
  • TABLE 221. TAIWAN IGE ALLERGY BLOOD TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 222. THAILAND IGE ALLERGY BLOOD TESTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 223. THAILAND IGE ALLERGY BLOOD TESTS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 224. THAILAND IGE ALLERGY BLOOD TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. THAILAND IGE ALLERGY BLOOD TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 226. THAILAND IGE ALLERGY BLOOD TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 227. THAILAND IGE ALLERGY BLOOD TESTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 228. THAILAND IGE ALLERGY BLOOD TESTS MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. THAILAND IGE ALLERGY BLOOD TESTS MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
  • TABLE 230. THAILAND IGE ALLERGY BLOOD TESTS MARKET SIZE, BY INHALANT ALLERGENS, 2018-2030 (USD MILLION)
  • TABLE 231. THAILAND IGE ALLERGY BLOOD TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 232. VIETNAM IGE ALLERGY BLOOD TESTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 233. VIETNAM IGE ALLERGY BLOOD TESTS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 234. VIETNAM IGE ALLERGY BLOOD TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 235. VIETNAM IGE ALLERGY BLOOD TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 236. VIETNAM IGE ALLERGY BLOOD TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 237. VIETNAM IGE ALLERGY BLOOD TESTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 238. VIETNAM IGE ALLERGY BLOOD TESTS MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 239. VIETNAM IGE ALLERGY BLOOD TESTS MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
  • TABLE 240. VIETNAM IGE ALLERGY BLOOD TESTS MARKET SIZE, BY INHALANT ALLERGENS, 2018-2030 (USD MILLION)
  • TABLE 241. VIETNAM IGE ALLERGY BLOOD TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY INHALANT ALLERGENS, 2018-2030 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 253. DENMARK IGE ALLERGY BLOOD TESTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 254. DENMARK IGE ALLERGY BLOOD TESTS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 255. DENMARK IGE ALLERGY BLOOD TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 256. DENMARK IGE ALLERGY BLOOD TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 257. DENMARK IGE ALLERGY BLOOD TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 258. DENMARK IGE ALLERGY BLOOD TESTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 259. DENMARK IGE ALLERGY BLOOD TESTS MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 260. DENMARK IGE ALLERGY BLOOD TESTS MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
  • TABLE 261. DENMARK IGE ALLERGY BLOOD TESTS MARKET SIZE, BY INHALANT ALLERGENS, 2018-2030 (USD MILLION)
  • TABLE 262. DENMARK IGE ALLERGY BLOOD TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 263. EGYPT IGE ALLERGY BLOOD TESTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 264. EGYPT IGE ALLERGY BLOOD TESTS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 265. EGYPT IGE ALLERGY BLOOD TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 266. EGYPT IGE ALLERGY BLOOD TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 267. EGYPT IGE ALLERGY BLOOD TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 268. EGYPT IGE ALLERGY BLOOD TESTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 269. EGYPT IGE ALLERGY BLOOD TESTS MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 270. EGYPT IGE ALLERGY BLOOD TESTS MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
  • TABLE 271. EGYPT IGE ALLERGY BLOOD TESTS MARKET SIZE, BY INHALANT ALLERGENS, 2018-2030 (USD MILLION)
  • TABLE 272. EGYPT IGE ALLERGY BLOOD TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 273. FINLAND IGE ALLERGY BLOOD TESTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 274. FINLAND IGE ALLERGY BLOOD TESTS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 275. FINLAND IGE ALLERGY BLOOD TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 276. FINLAND IGE ALLERGY BLOOD TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 277. FINLAND IGE ALLERGY BLOOD TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 278. FINLAND IGE ALLERGY BLOOD TESTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 279. FINLAND IGE ALLERGY BLOOD TESTS MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 280. FINLAND IGE ALLERGY BLOOD TESTS MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
  • TABLE 281. FINLAND IGE ALLERGY BLOOD TESTS MARKET SIZE, BY INHALANT ALLERGENS, 2018-2030 (USD MILLION)
  • TABLE 282. FINLAND IGE ALLERGY BLOOD TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 283. FRANCE IGE ALLERGY BLOOD TESTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 284. FRANCE IGE ALLERGY BLOOD TESTS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 285. FRANCE IGE ALLERGY BLOOD TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 286. FRANCE IGE ALLERGY BLOOD TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 287. FRANCE IGE ALLERGY BLOOD TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 288. FRANCE IGE ALLERGY BLOOD TESTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 289. FRANCE IGE ALLERGY BLOOD TESTS MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 290. FRANCE IGE ALLERGY BLOOD TESTS MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
  • TABLE 291. FRANCE IGE ALLERGY BLOOD TESTS MARKET SIZE, BY INHALANT ALLERGENS, 2018-2030 (USD MILLION)
  • TABLE 292. FRANCE IGE ALLERGY BLOOD TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 293. GERMANY IGE ALLERGY BLOOD TESTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 294. GERMANY IGE ALLERGY BLOOD TESTS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 295. GERMANY IGE ALLERGY BLOOD TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 296. GERMANY IGE ALLERGY BLOOD TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 297. GERMANY IGE ALLERGY BLOOD TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 298. GERMANY IGE ALLERGY BLOOD TESTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 299. GERMANY IGE ALLERGY BLOOD TESTS MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 300. GERMANY IGE ALLERGY BLOOD TESTS MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
  • TABLE 301. GERMANY IGE ALLERGY BLOOD TESTS MARKET SIZE, BY INHALANT ALLERGENS, 2018-2030 (USD MILLION)
  • TABLE 302. GERMANY IGE ALLERGY BLOOD TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 303. ISRAEL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 304. ISRAEL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 305. ISRAEL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 306. ISRAEL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 307. ISRAEL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 308. ISRAEL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 309. ISRAEL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 310. ISRAEL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
  • TABLE 311. ISRAEL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY INHALANT ALLERGENS, 2018-2030 (USD MILLION)
  • TABLE 312. ISRAEL IGE ALLERGY BLOOD TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 313. ITALY IGE ALLERGY BLOOD TESTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 314. ITALY IGE ALLERGY BLOOD TESTS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 315. ITALY IGE ALLERGY BLOOD TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 316. ITALY IGE ALLERGY BLOOD TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 317. ITALY IGE ALLERGY BLOOD TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 318. ITALY IGE ALLERGY BLOOD TESTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 319. ITALY IGE ALLERGY BLOOD TESTS MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 320. ITALY IGE ALLERGY BLOOD TESTS MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
  • TABLE 321. ITALY IGE ALLERGY BLOOD TESTS MARKET SIZE, BY INHALANT ALLERGENS, 2018-2030 (USD MILLION)
  • TABLE 322. ITALY IGE ALLERGY BLOOD TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 323. NETHERLANDS IGE ALLERGY BLOOD TESTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 324. NETHERLANDS IGE ALLERGY BLOOD TESTS MARKET SIZE, BY KITS, 2018-2030 (USD MILLION)
  • TABLE 325. NETHERLANDS IGE ALLERGY BLOOD TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 326. NETHERLANDS IGE ALLERGY BLOOD TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 327. NETHERLANDS IGE ALLERGY BLOOD TESTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 328. NETHERLANDS IGE ALLERGY BLOOD TESTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 329. NETHERLANDS IGE ALLERGY BLOOD TESTS MARKET SIZE, BY ALLERGEN TYPE, 2018-2030 (USD MILLION)
  • TABLE 330. NETHERLANDS IGE ALLERGY BLOOD TESTS MARKET SIZE, BY FOOD ALLERGENS, 2018-2030 (USD MILLION)
  • TABLE 331. NETHERLANDS IGE ALLERGY BLOOD TESTS MARKET SIZE, BY INHALANT ALLERGENS, 2018-2030 (USD MILLION)
  • TABLE 332. NETHERLANDS IGE ALLERGY BLOOD TESTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 333. NIGERIA IGE ALLERGY BLOOD TESTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 334. NIGERIA IGE ALLERGY BLOOD TESTS MARKET SI
目次
Product Code: MRR-546E6FBB35FC

The IgE Allergy Blood Tests Market was valued at USD 29.87 billion in 2023, expected to reach USD 31.49 billion in 2024, and is projected to grow at a CAGR of 5.29%, to USD 42.87 billion by 2030.

The scope of the IgE Allergy Blood Tests market encompasses the quantification of allergen-specific immunoglobulin E (IgE) levels in the blood to diagnose allergic conditions. These tests are essential for healthcare providers to identify allergens responsible for hypersensitivity reactions, offering a comprehensive solution for diagnosing allergies compared to skin tests, particularly in patients with skin conditions or those on medications that interfere with other testing methods. The application pertains chiefly to diagnosing allergic rhinitis, asthma, food allergies, and atopic dermatitis across varied healthcare settings, including hospitals, diagnostic laboratories, and research institutes. The end-use scope involves patients requiring precise allergy diagnosis due to unexplained respiratory or dermatological symptoms, or those with suspected food allergies.

KEY MARKET STATISTICS
Base Year [2023] USD 29.87 billion
Estimated Year [2024] USD 31.49 billion
Forecast Year [2030] USD 42.87 billion
CAGR (%) 5.29%

Key growth factors in this market include the increasing prevalence of allergic diseases, rising awareness regarding early diagnosis, and technological advancements in immunological assays improving sensitivity and specificity. Opportunities abound in emerging markets where healthcare infrastructure is rapidly developing, and there is increasing investment in personalized medicine. To capitalize on these, firms should focus on geographic expansion and strategic partnerships with healthcare providers to enhance accessibility. Innovations in automated testing platforms and development of multiplex assays can significantly enhance market penetration.

Challenges include the high cost of testing, regulatory compliance complexities, and competition from alternative diagnostic modalities like skin prick tests that are cheaper and easier to perform in clinical practice. Additionally, limited awareness in certain regions hampers market growth. To address these limitations, businesses can invest in cost-effective manufacturing techniques and extensive market education campaigns.

Areas of innovation include developing high-throughput screening tests, integrating artificial intelligence for predictive diagnostics, and expanding the database of allergens to improve accuracy and reliability. Insights suggest a nature of market that is competitive yet rewarding for firms adopting scalable innovations and focusing on patient-centric solutions. Strategic emphasis on affordability, accuracy, and accessibility can enhance market growth and broaden diagnostic capabilities.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving IgE Allergy Blood Tests Market

The IgE Allergy Blood Tests Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of allergies leading to higher demand for diagnostic tests including IgE Allergy Blood Tests
    • Technological advancements in diagnostic equipment contributing to more accurate and reliable IgE Allergy Blood Tests
    • Growing awareness among patients and healthcare providers about the benefits of early allergy detection and management
    • The rise in healthcare expenditure and improved healthcare infrastructure facilitating easier access to IgE Allergy Blood Testing
  • Market Restraints
    • The high cost of IgE allergy blood tests limits their adoption among patients and healthcare providers
    • The limited availability of trained professionals and specialized laboratories hampers the widespread use of IgE allergy blood tests in remote and underserved regions
  • Market Opportunities
    • Government initiatives promoting allergy testing and management increasing adoption of IgE tests
    • Expanding healthcare infrastructure in emerging markets driving growth for IgE allergy blood tests
    • Partnerships between diagnostic labs and healthcare providers enhancing the market for IgE tests
  • Market Challenges
    • Limited awareness and understanding of IgE blood tests among healthcare providers and patients
    • Fragmented regulatory landscape complicating approval processes for new test methods

Porter's Five Forces: A Strategic Tool for Navigating the IgE Allergy Blood Tests Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the IgE Allergy Blood Tests Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the IgE Allergy Blood Tests Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the IgE Allergy Blood Tests Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the IgE Allergy Blood Tests Market

A detailed market share analysis in the IgE Allergy Blood Tests Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the IgE Allergy Blood Tests Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the IgE Allergy Blood Tests Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the IgE Allergy Blood Tests Market

A strategic analysis of the IgE Allergy Blood Tests Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the IgE Allergy Blood Tests Market, highlighting leading vendors and their innovative profiles. These include Abcam plc, Allergy Therapeutics, Bindley Western Industries, Inc., bioMerieux SA, Creative Diagnostics, Danaher Corporation, DRG International, Inc., EUROIMMUN Medizinische Labordiagnostika AG, HYCOR Biomedical, Inc., Lincoln Diagnostics, Inc., MEDIWISS ANALYTIC GmbH, Meso Scale Diagnostics, LLC, Omega Diagnostics Group PLC, PerkinElmer, Inc., R-Biopharm AG, Randox Laboratories Ltd., Siemens Healthineers AG, Stallergenes Greer Ltd, Tecan Group Ltd., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the IgE Allergy Blood Tests Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Instruments, Kits, and Reagents. The Kits is further studied across Custom Kits and Standard Kits.
  • Based on Test Type, market is studied across Specific IgE Test and Total IgE Test.
  • Based on Application, market is studied across Diagnostics, Drug Development, and Research.
  • Based on End User, market is studied across Academic and Research Institutes, Hospitals, Pharmaceutical and Biotechnology Companies, and Reference Laboratories. The Hospitals is further studied across Private Hospitals and Public Hospitals.
  • Based on Allergen Type, market is studied across Animal Allergens, Drug Allergens, Food Allergens, and Inhalant Allergens. The Food Allergens is further studied across Egg, Milk, Peanut, Seafood, Soy, Tree Nuts, and Wheat. The Inhalant Allergens is further studied across Dust Mites, Mold, and Pollen.
  • Based on Distribution Channel, market is studied across Direct Sales and Distributor Sales.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of allergies leading to higher demand for diagnostic tests including IgE Allergy Blood Tests
      • 5.1.1.2. Technological advancements in diagnostic equipment contributing to more accurate and reliable IgE Allergy Blood Tests
      • 5.1.1.3. Growing awareness among patients and healthcare providers about the benefits of early allergy detection and management
      • 5.1.1.4. The rise in healthcare expenditure and improved healthcare infrastructure facilitating easier access to IgE Allergy Blood Testing
    • 5.1.2. Restraints
      • 5.1.2.1. The high cost of IgE allergy blood tests limits their adoption among patients and healthcare providers
      • 5.1.2.2. The limited availability of trained professionals and specialized laboratories hampers the widespread use of IgE allergy blood tests in remote and underserved regions
    • 5.1.3. Opportunities
      • 5.1.3.1. Government initiatives promoting allergy testing and management increasing adoption of IgE tests
      • 5.1.3.2. Expanding healthcare infrastructure in emerging markets driving growth for IgE allergy blood tests
      • 5.1.3.3. Partnerships between diagnostic labs and healthcare providers enhancing the market for IgE tests
    • 5.1.4. Challenges
      • 5.1.4.1. Limited awareness and understanding of IgE blood tests among healthcare providers and patients
      • 5.1.4.2. Fragmented regulatory landscape complicating approval processes for new test methods
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. IgE Allergy Blood Tests Market, by Product Type

  • 6.1. Introduction
  • 6.2. Instruments
  • 6.3. Kits
    • 6.3.1. Custom Kits
    • 6.3.2. Standard Kits
  • 6.4. Reagents

7. IgE Allergy Blood Tests Market, by Test Type

  • 7.1. Introduction
  • 7.2. Specific IgE Test
  • 7.3. Total IgE Test

8. IgE Allergy Blood Tests Market, by Application

  • 8.1. Introduction
  • 8.2. Diagnostics
  • 8.3. Drug Development
  • 8.4. Research

9. IgE Allergy Blood Tests Market, by End User

  • 9.1. Introduction
  • 9.2. Academic and Research Institutes
  • 9.3. Hospitals
    • 9.3.1. Private Hospitals
    • 9.3.2. Public Hospitals
  • 9.4. Pharmaceutical and Biotechnology Companies
  • 9.5. Reference Laboratories

10. IgE Allergy Blood Tests Market, by Allergen Type

  • 10.1. Introduction
  • 10.2. Animal Allergens
  • 10.3. Drug Allergens
  • 10.4. Food Allergens
    • 10.4.1. Egg
    • 10.4.2. Milk
    • 10.4.3. Peanut
    • 10.4.4. Seafood
    • 10.4.5. Soy
    • 10.4.6. Tree Nuts
    • 10.4.7. Wheat
  • 10.5. Inhalant Allergens
    • 10.5.1. Dust Mites
    • 10.5.2. Mold
    • 10.5.3. Pollen

11. IgE Allergy Blood Tests Market, by Distribution Channel

  • 11.1. Introduction
  • 11.2. Direct Sales
  • 11.3. Distributor Sales

12. Americas IgE Allergy Blood Tests Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific IgE Allergy Blood Tests Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa IgE Allergy Blood Tests Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2023
  • 15.2. FPNV Positioning Matrix, 2023
  • 15.3. Competitive Scenario Analysis
  • 15.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abcam plc
  • 2. Allergy Therapeutics
  • 3. Bindley Western Industries, Inc.
  • 4. bioMerieux SA
  • 5. Creative Diagnostics
  • 6. Danaher Corporation
  • 7. DRG International, Inc.
  • 8. EUROIMMUN Medizinische Labordiagnostika AG
  • 9. HYCOR Biomedical, Inc.
  • 10. Lincoln Diagnostics, Inc.
  • 11. MEDIWISS ANALYTIC GmbH
  • 12. Meso Scale Diagnostics, LLC
  • 13. Omega Diagnostics Group PLC
  • 14. PerkinElmer, Inc.
  • 15. R-Biopharm AG
  • 16. Randox Laboratories Ltd.
  • 17. Siemens Healthineers AG
  • 18. Stallergenes Greer Ltd
  • 19. Tecan Group Ltd.
  • 20. Thermo Fisher Scientific Inc.